EMMPRIN

EMMPRIN 분자 정보

영어 이름Basigin시판 약물 수1
임상 약물 수4표적 별명BSG,Extracellular matrix metalloproteinase inducer,UNQ6505/PRO21383,Basigin (Ok Blood Group),Tumor Cell-Derived Collagenase Stimulatory Factor,Leukocyte Activation Antigen M6,Collagenase Stimulatory Factor,Basigin,5F7,Ok Blood Group,CD147 Antigen,EMPRIN,CD147,OK,TCSF,EMMPRIN,SLC7A11,OK blood group antigen
최고 연구 개발 단계Approved
영어 이름Basigin
표적 별명BSG,Extracellular matrix metalloproteinase inducer,UNQ6505/PRO21383,Basigin (Ok Blood Group),Tumor Cell-Derived Collagenase Stimulatory Factor,Leukocyte Activation Antigen M6,Collagenase Stimulatory Factor,Basigin,5F7,Ok Blood Group,CD147 Antigen,EMPRIN,CD147,OK,TCSF,EMMPRIN,SLC7A11,OK blood group antigen
시판 약물 수1
임상 약물 수4
최고 연구 개발 단계Approved

EMMPRIN 제품 목록

  • 속성

    Protein (6)

  • 제품 라이브러리

    온라인 (6)

  • Human (4)Mouse (1)Cynomolgus (1)

  • 태그

    His Tag (3)Fc Tag (1)His Tag & Avi Tag (2)

  • 마커

    Unconjugated (3)Biotin-labeled (2)FITC Labeled (1)

EMMPRIN분자 배경

CD147, also known as Basigin (BSG), or extracellular matrix metalloproteinase inducer (EMMPRIN). The human basigin protein contains 269 amino acids that form two heavily glycosylated C2 type immunoglobulin-like domains at the N-terminal extracellular portion. A second form of basigin has also been characterized that contains one additional immunoglobulin-like domain in its extracellular portion. As members of the immunoglobulin superfamily play fundamental roles in intercellular recognition involved in various immunologic phenomena, differentiation, and development, basigin is thought also to play a role in intercellular recognition and regulate several distinct functions, such as spermatogenesis, expression of the monocarboxylate transporter and the responsiveness of lymphocytes. Basigin is a type I integral membrane receptor that has many ligands, including the cyclophilin (CyP) proteins Cyp-A and CyP-B and certain integrins.

EMMPRIN분자 별명

Basigin,BSG,5F7,CD147,EMMPRIN,M6,OK,TCSF

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
MertuzumabPhase 3 ClinicalInstitute Of Medicine Fourth Military Medical University, Jiangsu Pacific Minok Biopharmaceutical Co., Ltd.Carcinoma, Non-Small-Cell Lung; Coronavirus Disease 2019 (COVID-19)
상세
MeplazumabHI6H8Phase 3 ClinicalInstitute Of Medicine Fourth Military Medical University, Jiangsu Pacific Minok Biopharmaceutical Co., Ltd.Coronavirus Disease 2019 (COVID-19); Malaria; Malaria, Falciparum; Post-Acute COVID-19 Syndrome
상세
humanized ADCC cHAb18 antibody (Pacific Meinuoke/Fourth Military Medical University)Phase 1 ClinicalAir Force Medical UniversityCarcinoma, Non-Small-Cell Lung
상세
CD147-CAR T cell therapy (Peking University People's Hospital)Phase 1 ClinicalPeking University People'S HospitalLymphoma, T-Cell
상세

시판 약물 정보

영어 이름연구 코드연구 개발 단계회사가장 빠른 브랜드 이름가장 빠른 승인 국가가장 빠른 적응증가장 빠른 승인 회사가장 빠른 승인 날짜적응증임상 시험
Iodine[131I] MetuximabApprovedChengdu Huasun Biotechnology Co LtdLicartin, 利卡汀Mainland ChinaCarcinoma, HepatocellularChengdu Huasun Biotechnology Co Ltd2006-10-12Carcinoma, Hepatocellular
상세
  • 분자 정보
  • 제품 목록
  • 시판 약물 정보
  • 임상 약물 정보
문의하기

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521

주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호